Skip to content
  • Sunday 15th November 2026
    • Healthier Welfare

    Healthier Welfare

    Nurturing Health and Well-being for All

    • Home
    • Arrowhead

    Tag: Arrowhead

    • pharma

    Arrowhead FY2026 earnings reveal costly R&D challenges

    Arrowhead FY2026 earnings show costly R&D must deliver results as market shifts focus on RNAi technology.

    View the post
    Oliver EdwardsNovember 14, 2026
    Tags: Arrowheadearnings analysisFY2026market trendspharmaceuticalsR&D costsRNAi

    Contact us

    Archives

    • November 2026
    • October 2026
    • September 2026
    • November 2025
    • October 2025
    • August 2025
    • July 2025
    • November 2024
    • December 2023
    • March 2023
    • November 2022

    Categories

    • Banking News
    • Beauty&Style
    • Dental
    • Diet
    • finance
    • Fitness&Exercise
    • Food&Recipe
    • general news
    • Health
    • Live Gaming
    • Medicalcare
    • pharma
    • Pharma News
    • pharmaceuticals
    • Weightloss
    • Yoga

    Popular News

    • Arrowhead FY2026 earnings
      November 14, 2026Oliver Edwards

      Arrowhead FY2026 earnings reveal costly R&D challenges

    • Theon Group acquisition
      November 11, 2026Oliver Edwards

      Theon Group acquisition: Is it the best move for Maneesh Pharma?

    • J&J Rybrevant Faspro approval
      November 7, 2026Oliver Edwards

      J&J Rybrevant Faspro Approval: Quick and Proven Treatment

    • November 3, 2026Oliver Edwards

      Kotak Mahindra Bank acquisition: A Smart Move for Growth

    • October 31, 2026Oliver Edwards

      Venetoclax Tablets approval: Is it the Best Treatment Option?

    Pages

    • About Us
    • Contact Us
    • Write for Us
    • Terms of Use
    • Disclaimer
    • Advertise with Us

    Recent Post

    • Arrowhead FY2026 earnings
      November 14, 2026Oliver Edwards

      Arrowhead FY2026 earnings reveal costly R&D challenges

    • Theon Group acquisition
      November 11, 2026Oliver Edwards

      Theon Group acquisition: Is it the best move for Maneesh Pharma?

    • J&J Rybrevant Faspro approval
      November 7, 2026Oliver Edwards

      J&J Rybrevant Faspro Approval: Quick and Proven Treatment

    • November 3, 2026Oliver Edwards

      Kotak Mahindra Bank acquisition: A Smart Move for Growth

    • October 31, 2026Oliver Edwards

      Venetoclax Tablets approval: Is it the Best Treatment Option?

    About Us·Contact Us·Write for Us·Terms of Use·Disclaimer·Advertise with Us

    Tags

    Alembic Pharmaceuticals Arrowhead business expansion cancer treatment Drug Approval drug efficacy drug prices drug pricing ear infection drug earnings analysis FDA FDA approval financial services FY2026 healthcare healthcare savings healthcare transparency India India Today industry news medical bills medical devices medical news medication MRP disclosure oncology pancreatic cancer patient access patient safety pharmaceutical acquisition pharmaceutical news pharmaceutical pricing pharmaceutical regulations pharmaceuticals pharma news pharma operations price cuts regulatory issues RNAi RVMD Stocktwits Unit VI USFDA USFDA approval Venetoclax

    Yoga

    • March 9, 2023March 22, 2023Donald Bell

      The Science of Yoga: How it Affects the Brain and Body

    • March 9, 2023March 22, 2023Donald Bell

      Yoga for Beginners: Tips and Tricks to Get Started

    • March 9, 2023March 22, 2023Donald Bell

      Exploring Different Types of Yoga: Find Your Perfect Practice

    • March 9, 2023March 22, 2023Donald Bell

      The Benefits of Yoga for Mind and Body

    • March 9, 2023March 22, 2023Donald Bell

      Why Yoga is the Perfect Cross-Training Activity for Athletes

    Featured

    Copyright All rights reserved.Theme Bulletin News by Shadow Themes